Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
EmailIphone Application    Posted: 29th August 2023
If you would like to forward this story on to a friend, simply fill in the form below and click send.
Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Blood molecules may identify between feline gut conditions
A blood molecule, miR-223-3p, was found to be particularly useful for diagnosing between cancer and chronic inflammation using blood.

MicroRNA could identify cancer and chronic bowel inflammation, study finds.

Biological molecules found in the blood samples of cats could distinguish between gastrointestinal cancer and chronic bowel inflammatory diseases, a study has suggested.

The study, led by the University of Copenhagen with the Royal (Dick) School of Veterinary Studies and researchers in Denmark, Scotland, Norway and Spain, aimed to find a test that would accurately identify between the clinically similar gut conditions.

The research involved studies into fragments of genetic material known as microRNA from the blood serum and faecal samples of healthy and unwell cats.

A blood molecule, miR-223-3p, was found to be particularly useful for diagnosing between cancer and chronic inflammation using blood.

This molecule could signify the early stages of a blood test being used to identify between the gastrointestinal conditions.

This test may prove to be more accurate than diagnosing the conditions using clinical observations of persistent or recurring weight loss, dysrexia and vomiting, which does not distinguish between the two conditions.

Similarly, if successful, this blood test could be less expensive and less invasive than diagnostic assessments such as histopathology, immunohistochemistry or clonality testing, which are often used to identify between the illnesses.

Although the research is in its early stages, the use of microRNA as a reliable and non-invasive biomarker of gastrointestinal cancer or chronic bowel inflammation could provide an alternative method of diagnosis than current approaches. This could mean it is easier to diagnose these conditions to initiate specific treatments and improve patient quality of life and survival.

Professor Silke Salavati, of the Royal (Dick) School of Veterinary Studies, said: “Vet professionals face a difficult task when diagnosing chronic bowel inflammation or cancer in felines, as symptoms for both conditions are often very similar.

“Through an international collaborative effort, our research underscores the potential of microRNAs as a diagnostic tool for veterinary medicine. Developing this method further could offer a good alternative to current approaches.”

Image (C) Shutterstock

Become a member or log in to add this story to your CPD history

Webinar to explore history of KC breed registers

News Story 1
 A free webinar exploring the development of the Kennel Club's registration system and the evolution of closed breed registers has been announced.

Hosted by Dr Alison Skipper, veterinary and research advisor at the Kennel Club, the webinar will delve into the development of the registry and how the changing landscape of scientific knowledge has shaped breeding practices. It will also look at what this means for the future of pedigree dogs.

The session will culminate with a look at The Kennel Club's ongoing and future engagement in this area, with a chance for attendees to put forward their thoughts and questions for discussion.

This event takes place on Microsoft Teams on Tuesday, 10 June at 7pm. To learn more, visit events.teams.microsoft.com  

Click here for more...
News Shorts
UK's BSE risk status downgraded

The WOAH has downgraded the UK's international risk status for BSE to 'negligible'.

Defra says that the UK's improved risk status recognises the reputation for having the highest standards for biosecurity. It adds that it demonstrates decades of rigorous animal control.

Outbreaks of Bovine Spongiform Encephalopathy, also known as mad cow disease, have previously resulted in bans on Britain's beef exports.

The UK's new status could lead to expanded trade and better confidence in British beef.

Christine Middlemiss, the UK's chief veterinary officer, said: "WOAH's recognition of the UK as negligible risk for BSE is a significant milestone and is a testament to the UK's strong biosecurity measures and the hard work and vigilance of farmers and livestock keepers across the country who have all played their part in managing the spread of this disease.